ATE170075T1 - Antivirales arzneimittel enthaltend prostratin - Google Patents

Antivirales arzneimittel enthaltend prostratin

Info

Publication number
ATE170075T1
ATE170075T1 AT91910575T AT91910575T ATE170075T1 AT E170075 T1 ATE170075 T1 AT E170075T1 AT 91910575 T AT91910575 T AT 91910575T AT 91910575 T AT91910575 T AT 91910575T AT E170075 T1 ATE170075 T1 AT E170075T1
Authority
AT
Austria
Prior art keywords
antiviral
prostratin
present
product containing
medicinal product
Prior art date
Application number
AT91910575T
Other languages
English (en)
Inventor
Michael R Boyd
Paul A Cox
Gordon M Cragg
Peter M Blumberg
Nancy A Sharkey
Junichi Ishitoya
James B Mcmahon
John A Beutler
Owen S Weislow
John H Ii Cardellina
Kirk R Gustafson
Original Assignee
Us Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Health filed Critical Us Health
Application granted granted Critical
Publication of ATE170075T1 publication Critical patent/ATE170075T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT91910575T 1990-05-30 1991-05-24 Antivirales arzneimittel enthaltend prostratin ATE170075T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US53056290A 1990-05-30 1990-05-30

Publications (1)

Publication Number Publication Date
ATE170075T1 true ATE170075T1 (de) 1998-09-15

Family

ID=24114097

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91910575T ATE170075T1 (de) 1990-05-30 1991-05-24 Antivirales arzneimittel enthaltend prostratin

Country Status (10)

Country Link
US (1) US5599839A (de)
EP (1) EP0531413B1 (de)
JP (1) JPH0737380B2 (de)
AT (1) ATE170075T1 (de)
AU (1) AU639343B2 (de)
CA (1) CA2083945C (de)
DE (1) DE69130063T2 (de)
DK (1) DK0531413T3 (de)
ES (1) ES2120962T3 (de)
WO (1) WO1991018595A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8022103B2 (en) 2005-07-13 2011-09-20 Salvia Sciences, Inc. Ester prodrugs of prostratin and related phorbol compounds
US10369222B2 (en) 2012-01-18 2019-08-06 Biosuccess Biotech Co., Ltd. Compositions and methods of use of phorbol esters for the treatment of stroke
PT2368555T (pt) * 2007-01-31 2016-07-25 Biosuccess Biotech Company Composições e métodos de utilização de ésteres de forbol
US9974764B2 (en) 2007-01-31 2018-05-22 Biosuccess Biotech Co. Ltd. Compositions and methods of use of phorbol esters in the treatment of neoplasms
US11696908B2 (en) 2007-01-31 2023-07-11 Biosuccess Biotech Co. Ltd. Compositions and methods of use of phorbol esters
US9533938B2 (en) 2007-01-31 2017-01-03 Biosuccess Biotech Co., Ltd. Compositions and methods of use of phorbol esters for the treatment of stroke
US11564901B2 (en) 2007-01-31 2023-01-31 Biosuccess Biotech Co., Ltd. Compositions and methods of use of phorbol esters
US9636317B2 (en) 2007-01-31 2017-05-02 Biosuccess Biotech Co. Ltd. Compositions and methods of use of phorbol esters
US8067632B2 (en) 2007-07-26 2011-11-29 The Board Of Trustees Of The Leland Stanford Junior University Process to produce prostratin and structural or functional analogs thereof
EP2276478A4 (de) * 2008-04-11 2012-03-07 Aids Res Alliance Verfahren zur verabreichung von prostratin und strukturellen analoga davon
US20100298171A1 (en) * 2009-05-22 2010-11-25 Affymetrix, Inc. Apparatus for polymer synthesis
WO2011014561A1 (en) * 2009-07-29 2011-02-03 He Johnny J Extracts of medicinal plant and uses thereof
US10099996B2 (en) 2012-01-18 2018-10-16 Biosuccess Biotech Co. Ltd. Compositions and methods of use of phorbol esters in the treatment of neoplasms
US9550722B2 (en) 2012-01-18 2017-01-24 Biosuccess Biotech Co. Ltd. Compositions and methods of use of phorbal esters for the treatment of stroke
ITUB20153575A1 (it) * 2015-09-11 2017-03-11 Fca Italy Spa "Sospensione per una ruota sterzante di autoveicolo, con asse di sterzo semi-virtuale"

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4902716A (en) * 1984-12-18 1990-02-20 Harbor Branch Oceanographic Institutuion, Inc. Anti-viral chamigrene derivatives

Also Published As

Publication number Publication date
WO1991018595A1 (en) 1991-12-12
JPH0737380B2 (ja) 1995-04-26
JPH05506451A (ja) 1993-09-22
AU639343B2 (en) 1993-07-22
US5599839A (en) 1997-02-04
AU7909991A (en) 1991-12-31
ES2120962T3 (es) 1998-11-16
DE69130063T2 (de) 1999-02-25
EP0531413A4 (en) 1993-06-16
CA2083945C (en) 1995-02-07
DK0531413T3 (da) 1999-05-25
DE69130063D1 (de) 1998-10-01
EP0531413B1 (de) 1998-08-26
EP0531413A1 (de) 1993-03-17

Similar Documents

Publication Publication Date Title
MD1224B2 (en) Application of nucleoside analogues with 1,3-oxathiolan for treatment of hepatitis B
ATE170075T1 (de) Antivirales arzneimittel enthaltend prostratin
FI862011A (fi) Terapeutiska nukleosider.
DE69333321D1 (de) Verwendung eines Consensus-Interferons zur Reduzierung der Nebeneffekte in der Interferon Behandlung von viralen Hepatiten.
EP0513702A3 (de) Melatoninderivate zur Behandlung von Schlafstörungen und zur Pre-Anästhesie
AR012614A1 (es) Una composicion farmaceutica para la fabricacion de un medicamento destinado para el tratamiento de una infeccion viral susceptible de tratamientocon interferon alfa, un metodo para la fabricacion de un medicamento, el uso de peg12000-ifn alfa para la fabricacion de un medicamento
FI922325A (fi) Oral sammansaettning foer botning av inflammatoriska tarmkanalsjukdomar.
DE69426334T2 (de) Parenterales Busulfan zur Behandlung von malignen Krankheiten
MY108146A (en) Medicaments for treating inflammatory conditions or for analgesia
HU907654D0 (en) Process for the production of medical preparations with increased stabilization, and without tissue-harming effect
AU563831B2 (en) N-(2-amino-3,5-dibromobenzyl)- trans-4-amino-cyclohexanol derivatives
IL88971A0 (en) Disubstituted pyridines,their preparation and pharmaceutical compositions containing them
HU9201358D0 (en) 2-amino-pirimidine-4-carboxamide derivatives, process for their production and for the production of medical preparations containing them as active agents
CA2255856A1 (en) Therapeutic uses for an aminosterol compound
IL111138A (en) Pharmaceutical compositions comprising penciclovir and/or its bioprecursor and/or its derivatives for the treatment and prophylaxis of post-herpetic neuralgia
AU1447892A (en) Pharmaceutical preparations for the therapy of tumors containing colchicine as the active principle and methods for the use of the same
GR3017335T3 (en) Oligophosphates with antiviral activity.
ATE210445T1 (de) Verwendung von 2-aminopurinderivaten zur behandlung und prophylaxe der menschlichen herpesvirus 7 infektionen
EP0132772A3 (en) Fr-900216 substance obtainable by cultivating atcc 20577 for use as an active therapeutic substance and pharmaceutical antitumor composition comprising fr-900216 substance
AP9200405A0 (en) Pharmaceutical formulations comprised of micronised halofantrine.
KR920009403A (ko) 수면장해 치료용 이미다조벤조디아제핀
ES2150400A6 (es) Una composicion para el tratamiento de desordenes ulcerosos del tracto gastrointestinal.
ATE280584T1 (de) Verwendung von beta interferon zur herstellung eines arzneimittels zur behandlung von ewings sarkom und eoe
MY119359A (en) Use of consensus interferon for reducing the side effects of interferon treatment in viral hepatitis.
IT1243368B (it) Uso del bendazac e dei suoi sali farmaceuticamente accettabili

Legal Events

Date Code Title Description
EELA Cancelled due to lapse of time